Abstract
Cystic fibrosis (CF), a common lethal inherited disorder defined by ion transport abnormalities, chronic infection, and robust inflammation, is the result of mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein, a cAMP-activated chloride (Cl−) channel. Macrophages are reported to have impaired activity in CF. Previous studies suggest that Cl− transport is important for macrophage function; therefore, impaired Cl− secretion may underlie CF macrophage dysfunction. To determine whether alterations in Cl− transport exist in CF macrophages, Cl− efflux was measured using N-[ethoxycarbonylmethyl]-6-methoxy-quinolinium bromide (MQAE), a fluorescent indicator dye. The contribution of CFTR was assessed by calculating Cl− flux in the presence and absence of cftrinh-172. The contribution of calcium (Ca2+)-modulated Cl− pathways was assessed by examining Cl− flux with varied extracellular Ca2+ concentrations or after treatment with carbachol or thapsigargin, agents that increase intracellular Ca2+ levels. Our data demonstrate that CFTR contributed to Cl− efflux only in WT macrophages, while Ca2+-mediated pathways contributed to Cl− transport in CF and WT macrophages. Furthermore, CF macrophages demonstrated augmented Cl− efflux with increases in extracellular Ca2+. Taken together, this suggests that Ca2+-mediated Cl− pathways are enhanced in CF macrophages compared with WT macrophages.
Similar content being viewed by others
Main
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that encodes a protein kinase A (PKA)-activated chloride (Cl−) channel. In the absence of functional CFTR, defective Cl− secretion impairs mucociliary clearance and results in viscous secretions in which bacteria proliferate, leading to an influx of immune cells (1,2). The subsequent robust inflammatory response contributes significantly to airway destruction, respiratory failure, and shortened life expectancy. Recent reports suggest that airway inflammation occurs early in life and can be observed before bacterial colonization. Increased numbers of neutrophils and increased IL-8, which may be partially macrophage-derived, have been noted without concomitant infection in the bronchoalveolar lavage (BAL) fluid of infants with CF (3). These findings suggest that if inflammation is present before infection, then macrophages may be important in stimulating the influx of neutrophils into the airways of these patients. Hubeau et al. (4) provided additional evidence that macrophages may contribute to this process as they reported increased numbers of macrophages in CF-affected fetal lung tissue in the absence of acute infection or concurrent increase in other immune cells or inflammatory markers. As macrophages are responsible for recruitment of immune cells to sites of inflammation, macrophage dysfunction in CF may result in altered responses to pathogenic stimuli.
If macrophage dysfunction contributes to the robust inflammatory response described in CF, it may be due to impaired Cl− transport, similar to the mechanism that underlies the pathology observed in CF-affected epithelia. Cl− flux has been described in macrophages at rest (5,6), during phagocytosis (7), after stimulation when it is associated with increased intracellular calcium (Ca2+) levels (8), and during macrophage activation when it is accompanied by changes in membrane potential. Despite these reports, the exact Cl− pathways and their roles in macrophage function have not been fully defined.
The aim of this study was to evaluate the Cl− efflux pathways present in macrophages. More specifically, to define the contributions of CFTR and Ca2+-activated Cl− pathways to total Cl− flux. Although CFTR activity has been reported in WT macrophages (9), its functional significance remains a question that requires further investigation. In addition, up-regulation of Ca2+-activated Cl− channels (CaCCs) has been well described in airway epithelia in the absence of functional CFTR (10), but it is unknown whether this relationship exists in nonepithelial cells. If this relationship is present in macrophages, then it may represent a potential pathway that can be targeted for novel therapeutic intervention. Cl− efflux was studied in murine bone marrow-derived (BMD) WT and CF macrophages to compare the contribution of these Cl− efflux pathways to total Cl− transport.
METHODS
Animals.
For all experiments outlined, two murine models of CF were used: a ΔF508 model (Cftrtm1Kt) (11) and a cftr−/− model (Cftrtm1UNC) (12). Both models have been fully backcrossed on a Bl6 background. They were bred and maintained as previously described (13–15). All procedures were performed in accordance with protocols approved by the Yale University Institutional Animal Care and Use Committee.
BMD macrophage isolation.
BM was obtained from long bones (hip, femur, and tibia) of mice (2–4 mo). Monocytic precursors were selected via Histopaque gradient. Following overnight culture, nonadherent macrophages were selectively grown in DMEM media (Invitrogen, Carlsbad, CA) with 10% FCS, l-glutamine, penicillin/streptomycin (100,000 units/mL), and 20 ng/mL recombinant murine macrophage colony stimulating factor (PeproTech Inc., Rocky Hill, NJ). Macrophages were cultured at 37°C with 5% CO2 for 9–14 d and then harvested with Neutral Protease (Worthington Co., Lakewood, NJ); 5–30 × 106 cells were obtained/mouse. Cultured macrophages are F480+/MAC-1+ as confirmed by flow cytometry (16). A suspension of 1 × 106 macrophages/mL concentration was used for experiments.
Fluorescent dye indicator studies.
Macrophages (∼1 × 105 cells), attached to glass coverslips precoated with Cell Tak (BD scientific laboratories, San Jose, CA), were incubated for 30 min at 37°C with N-[ethoxycarbonylmethyl]-6-methoxy-quinolinium bromide (MQAE, 30 mM) (17). MQAE (Invitrogen, Carlsbad, CA) is a Cl−-sensitive fluorescent indicator dye that measures increases in Cl− concentration via a quenching mechanism. Reductions in cell Cl− give increases in fluorescent intensity indicative of decreased cytosolic Cl− concentration (18). Dye loading and subsequent experimentation were performed in a custom perfusion chamber mounted on an Olympus IX-71 inverted microscope (19). MQAE was excited at 354 ± 10 nm, and emitted fluorescent light was measured at 460 ± 10 nm every 5 s using a charge coupled device camera attached to a digital imaging system (20,21). Typically, 10–20 macrophages were monitored simultaneously for each experiment. The rate of change in MQAE fluorescence [Δarbitrary fluorescent units (AFU)/Δtime (s)] was used to calculate Cl− efflux.
Initially, macrophages were perfused at 3–4 mL/min with Cl−-containing solution [135 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1.2 mM MgSO4, 2 mM NaH2PO4, 2 mM HEPES, and 10 mM glucose or as previously described (20)] to allow for removal of extraneous dye. After the initial perfusion with Cl−-containing buffer, the perfusate was changed to a Cl−-free solution [135 mM NaCyclamate, 3 mM KGluconate, 0.5 mM CaCyclamate, 1.2 mM MgSO4, 2 mM KH2PO4, 2 mM HEPES, and 10 mM Glucose or as previously described (20)] in which Cl− was substituted with cyclamate. In a subset of experiments, the loading of MQAE was assessed by exposing cells to a final perfusion solution containing potassium thiocyanate (KSCN) (150 mM KSCN, 0.5 mM CaCyclamate, 1.2 mM MgSO4, 2 mM KH2PO4, 2 mM HEPES, 10 mM Glucose) with Nigericin (10 μM) to measure the minimum specific fluorescence of the cells (20). The control Cl−-free solution contained 0.5 mM Ca2+, which is within the normal range for extracellular Ca2+ concentrations (22–25). The high Ca2+/Cl−-free solution had a Ca2+ concentration of 2 mM, which can be found in tracheobronchial secretions (26,27). Macrophages were assessed in a low Ca2+ (0.1 mM)/Cl−-free solution for comparison. To ensure that the extracellular Ca2+ concentrations did not affect cell viability, assays were performed with Trypan blue in each experimental solution demonstrating ≥90% viability. Solutions were adjusted to a final pH of 7.4 at 37°C and an osmolarity of 300 mOsmol.
To confirm the presence of Cl− movement, macrophages were assessed in the presence of 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB, 100 μM), a broad inhibitor of Cl− channels (28), as cells transitioned from Cl−-containing to Cl−-free solutions. The contribution of CFTR to total Cl− flux was evaluated in the presence of the CFTR-specific inhibitor, cftrinh-172 (20 μM). Macrophages were treated for 2 min with cftrinh-172 in the Cl−-containing solution before assessing Cl− efflux in the control Cl−-free solution with cftrinh-172 still present. Rates of Cl− efflux after treatment with either inhibitor were compared with rates of Cl− efflux observed in the absence of the inhibitors. Vehicles alone (ethanol or DMSO) had no effect on efflux.
The effect of increasing intracellular Ca2+ concentrations on Cl− efflux was assessed indirectly after treatment with either carbachol or thapsigargin. Macrophages were treated with carbachol (100 μM) for 30 min, while loading with MQAE (29). Alternatively, macrophages were assessed after treatment with thapsigargin (1 μM) for 2 min in Cl−-containing solution before assessment in Cl−-free solution. After treatment with either agent, Cl− efflux was assessed in either low Ca2+/Cl−-free solution with addition of EGTA (1 mM) or in the control solution. Chemicals were purchased from Sigma Chemical Co. Corporation unless specified.
Data analysis.
Maximal apparent Cl− efflux was calculated using GraphPad Prism version 5.01 for Windows (GraphPad Software, San Diego, CA) in conjunction with Microsoft Excel to compute the first derivative of the change in MQAE fluorescence over time (slope). The data are summarized as the mean Cl− efflux (ΔAFU/Δs) ± the SEM. An unpaired t test with Welch's correction (accounting for unequal variances) was performed to compare slopes between experimental conditions. A p value of <0.05 was considered statistically significant.
RESULTS
Chloride efflux is present in both CF-affected and WT macrophages.
Changes in MQAE fluorescence in Cl−-containing and control Cl−-free solutions for both WT and CF macrophages are represented in Figure 1. Cl− efflux, calculated as the rate of change in MQAE fluorescence (ΔAFU/Δs), was present in both genotypes. Cl− efflux was confirmed via the absence of flux in both WT and CF macrophages in the presence of NPPB (Fig. 2). The mean Cl− efflux (ΔAFU/Δs) was calculated for comparison between genotypes in control Cl−-free solution (Fig. 3). The Cl− efflux observed in WT macrophages (9.21 ± 0.51 AFU/s) was significantly greater than CF macrophages (3.22 ± 0.32 AFU/s, p < 0.0001). Furthermore, experiments performed with perfusion of KSCN solution demonstrated that MQAE fluorescence in macrophages was 4-fold greater than the background fluorescence.
CFTR contributes to the chloride efflux in macrophages.
To assess the specific contribution of functional CFTR to Cl− efflux, macrophages were studied in the presence and absence of cftrinh-172 (20 μM). After exposure to cftrinh-172, Cl− efflux in WT macrophages was significantly reduced (4.6 ± 0.42 AFU/s, p < 0.0001) compared with Cl− efflux observed under control conditions (Fig. 4). In contrast, cftrinh-172 had no appreciable effects on Cl− efflux in CF macrophages (3.9 ± 0.23 AFU/s, p = 0.09). Of note, in the presence of cftrinh-172, the rate of Cl− efflux observed in WT macrophages was equivalent to the rate observed in CF macrophages (p = 0.15).
The presence of Cl− efflux in CF and WT macrophages after treatment with cftrinh-172 suggests that non–CFTR-dependent Cl− pathways contributed to total Cl− efflux in macrophages. Previous studies in CF-affected epithelia have described an up-regulation of CaCCs (10), but this has not been studied in CF macrophages. Therefore, in subsequent experiments, the effects of Ca2+ on Cl− efflux were assessed in macrophages at various extracellular Ca2+ concentrations or after treatment with either carbachol or thapsigargin.
Extracellular calcium concentrations increase chloride efflux in CF-affected macrophages.
Extracellular Ca2+ concentrations affected Cl− efflux in both WT and CF macrophages. The rates of Cl− efflux were significantly diminished (1.6 ± 0.22 AFU/s and 2.56 ± 0.23 AFU/s, respectively, p < 0.0001) in low Ca2+ (0.1 mM) solution compared with rates of Cl− efflux observed in control (0.5 mM Ca2+) solution as shown in Figure 5A. In contrast, only CF-affected macrophages demonstrated a significant increase in Cl− efflux in high (2 mM) Ca2+ solution (6.86 ± 0.4 AFU/s, p = 0.0002; Fig. 5B). Similar changes were not observed in WT macrophages (7.64 ± 0.67 AFU/s, p = 0.12).
Because extracellular Ca2+ can ultimately affect intracellular Ca2+ levels, the effects of altering intracellular Ca2+ concentrations on Cl− efflux were subsequently assessed. Macrophages were exposed to carbachol, a combined muscarinic and nicotinic receptor agonist that stimulates Ca2+ release from intracellular stores (30). In addition, macrophages were exposed to thapsigargin, a sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) pump inhibitor that prevents Ca2+ sequestration into the endoplasmic reticulum (31).
Intracellular calcium concentrations modulate chloride efflux in CF macrophages.
After treatment with carbachol, only CF macrophages demonstrated a significant augmentation of Cl− efflux (11.16 ± 0.44 AFU/s, p < 0.0001; Fig. 6A). The enhanced rate of Cl− efflux observed in CF macrophages was greater than the rate observed in WT macrophages under control conditions (8.84 ± 0.36 AFU/s, p < 0.0001). In contrast, WT macrophages demonstrated a decrease in Cl− efflux after treatment with carbachol (6.82 ± 0.77 AFU/s, p = 0.019).
To confirm that the changes in Cl− flux observed after carbachol treatment were due to increased intracellular Ca2+ concentration rather than nonspecific effects, macrophages were assessed after treatment with thapsigargin. As shown in Figure 6B, Cl− efflux was significantly augmented in CF macrophages after treatment with thapsigargin (11.59 ± 0.57 AFU/s, p < 0.0001), providing support that Ca2+ mobilized in the setting of SERCA pump inhibition also enhanced Cl− efflux in these cells. In contrast, WT macrophages demonstrated no change in Cl− efflux after thapsigargin treatment (10.08 ± 0.95 AFU/s, p = 0.22).
Finally, to assess whether Ca2+ entry contributed to the observed increase in Cl− efflux, macrophages were assessed after treatments with either carbachol (Fig. 7A) or thapsigargin (Fig. 7B), while being perfused with a low extracellular Ca2+ solution containing EGTA (1 mM) to chelate external Ca2+ available. In the low Ca2+ solution, only CF macrophages demonstrated significant enhancement of Cl− efflux after treatment with carbachol (9.03 ± 0.55 AFU/s, p < 0.0001) and thapsigargin (13.82 ± 0.91 AFU/s, p < 0.0001). Interestingly, the rate of Cl− efflux observed in CF macrophages after thapsigargin treatment was greater than that observed in WT macrophages under all conditions studied. In contrast, rates of Cl− efflux were not similarly increased in WT macrophages after treatment with either carbachol (8.47 ± 0.96 AFU/s, p = 0.723) or thapsigargin (10.41 ± 0.69 AFU/s, p = 0.056). Taken together, these data suggest that it is unlikely Ca2+ entry significantly contributed or modulated the rates of Cl− efflux observed after carbachol or thapsigargin treatments.
DISCUSSION
CF has been described as a disease of the epithelia (32). However, the possibility that CFTR dysfunction affects nonepithelial cells, including primary immune cells, has been raised on numerous occasions (1,2). For instance, the BAL specimens from asymptomatic CF infants demonstrate increased levels of IL-8 that could be macrophage-derived (3). In addition, BAL specimens from older patients with CF demonstrate increased numbers of macrophages in combination with increased levels of chemokines, known to attract peripheral monocytes (33). In addition, after stimulation with lipopolysaccharide, CF mice exhibit increased levels of BAL cytokines, that are largely macrophage-derived, compared with WT littermates (16). Moreover, comparable abnormalities of cytokine secretion are observed in their BMD macrophages (16,34). These data suggest that there is a primary defect in CFTR-deficient monocytes that results in their increased activation. Despite these reports, there is no consensus that CFTR dysfunction directly contributes to these findings and thus the role of CFTR in macrophages remains speculative.
Reports suggest that ion channel conductances likely influence immune cell function (35); therefore, Cl− permeability may play a role in modulating macrophage activities. Previous studies demonstrated that swell-activated (36), voltage-gated (35), and Ca2+-dependent (8) Cl− pathways are present in macrophages. In addition, the presence of CFTR has been reported in WT macrophages (9). To date, the Cl− pathways that are present in CF macrophages, where CFTR is absent, are not well-characterized but may play a role in the CF inflammatory response. To our knowledge, this study is the first to compare the contributions of CFTR- and Ca2+-modulated Cl− pathways to total Cl− transport in CF and WT macrophages.
Our results demonstrate that although Cl− efflux is present in both WT and CF macrophages, the contribution of CFTR and other Cl− pathways to the total Cl− efflux is different for each genotype. The contribution of CFTR to Cl− efflux in WT macrophages is demonstrated clearly by the decreased rate of Cl− efflux observed in WT macrophages treated with cftrinh-172. In addition, non–CFTR-dependent Cl− efflux pathways are present in both CF and WT cells, as each genotype exhibits significant residual flux despite the absence of functional CFTR. Furthermore, these additional pathways are partially mediated by extracellular Ca2+ concentrations because a decrease in Cl− flux is observed in both genotypes when extracellular Ca2+ is reduced. Interestingly, only CF macrophages exhibit an increase in Cl− efflux when extracellular Ca2+ concentrations are increased.
The effects of extracellular Ca2+ concentrations on Cl− efflux were unexpected because the link between extracellular Ca2+ concentrations and Cl− flux is not overtly intuitive. It is possible that the presence of divalent cations may stabilize the open state of CFTR and allow for increased Cl− movement (37) as described previously. This would suggest that altering Ca2+ concentration may not only modulate Ca2+-mediated Cl− pathways but also potentially affect CFTR function in WT macrophages.
An alternative explanation for the effects of extracellular Ca2+ on Cl− efflux may be the presence of Ca2+ sensing receptors (CaSR) which have been described in BMD cells (38). Increases in extracellular Ca2+ concentrations would activate CaSRs leading to the release of intracellular Ca2+ stores (25), subsequently increasing Cl− flux via CaCCs. If this mechanism is present, then increased extracellular Ca2+ concentrations will result in an increase in Cl− efflux, whereas decreased extracellular Ca2+ concentrations should have the opposite effect. However, one must also postulate a difference in some portion of this pathway in CF or WT cells as only CF macrophages exhibited an augmentation of Cl− efflux when examined in high extracellular Ca2+ solution. In addition, after modulation of intracellular Ca2+ concentrations indirectly with carbachol or thapsigargin, only CF macrophages demonstrated a significant increase in Cl− efflux. Together, these findings suggest that Ca2+ modulates Cl− secretory pathways in CF and WT macrophages differently.
Interestingly, similar findings have been described in cftr−/− epithelia (10) suggesting Ca2+-modulated Cl− pathways may represent an alternative route for augmenting Cl− efflux in the absence of functional CFTR protein in multiple cell types (39–41). One could speculate that under certain circumstances, such as an acute inflammatory response, extracellular Ca2+ levels, which range from 1 to 4 mM in tracheobronchial secretions, could result in a more robust Cl− efflux in these CF macrophages to enhance their function.
However, the use of Ca2+-modulated Cl− pathways could also be detrimental in the overall CF inflammatory response. For instance, studies indicate that changes in Ca2+ mobilization and homeostasis within CF airway epithelia are linked with its predisposition to a hyperinflammatory phenotype (42–45). In addition, Mueller et al. (46) recently described that altered intracellular Ca2+ mobilization in cftr−/− lymphocytes led to the induction of inflammatory signaling pathways and cytokine secretion. Thus, the enhancement of Ca2+-modulated Cl− efflux pathways in our CF macrophages may be a potential mechanism by which macrophages directly contribute to the hyperinflammatory phenotype and airway pathophysiology observed in CF.
Abbreviations
- AFU:
-
arbitrary fluorescent units
- BAL:
-
bronchoalveolar lavage
- BMD:
-
bone marrow derived
- CaCC:
-
calcium-activated chloride channel
- CF:
-
cystic fibrosis
- CFTR:
-
cystic fibrosis transmembrane conductance regulator
- KSCN:
-
potassium thiocyanate
- MQAE:
-
N-[ethoxycarbonylmethyl]-6-methoxy-quinolinium bromide
- NPPB:
-
5-nitro-2-(3-phenylpropylamino)benzoic acid
References
Brennan S 2008 Innate immune activation and cystic fibrosis. Paediatr Respir Rev 9: 271–279, quiz 279–280.
Döring G, Gulbins E 2009 Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 11: 208–216
Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW 1995 Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075–1082
Hubeau C, Puchelle E, Gaillard D 2001 Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis. J Allergy Clin Immunol 108: 524–529
Robin ED, Smith JD, Tanser AR, Adamson JS, Millen JE, Packer B 1971 Ion and macromolecular transport in the alveolar macrophage. Biochim Biophys Acta 241: 117–128
Castranova V, Bowman L, Miles PR 1979 Transmembrane potential and ionic content of rat alveolar macrophages. J Cell Physiol 101: 471–479
Ince C, Coremans JM, Ypey DL, Leijh PC, Verveen AA, van Furth R 1988 Phagocytosis by human macrophages is accompanied by changes in ionic channel currents. J Cell Biol 106: 1873–1878
Holevinsky KO, Jow F, Nelson DJ 1994 Elevation in intracellular calcium activates both chloride and proton currents in human macrophages. J Membr Biol 140: 13–30
Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ 2006 CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8: 933–944
Grubb BR, Vick RN, Boucher RC 1994 Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl− secretion in nasal epithelia of CF mice. Am J Physiol 266: C1478–C1483
Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McCray PB Jr, Capecchi MR, Welsh MJ, Thomas KR 1995 A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 96: 2051–2064
Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH 1992 An animal model for cystic fibrosis made by gene targeting. Science 257: 1083–1088
Bruscia EM, Ziegler EC, Price JE, Weiner S, Egan ME, Krause DS 2006 Engraftment of donor-derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 24: 2299–2308
Rosenberg LA, Schluchter MD, Parlow AF, Drumm ML 2006 Mouse as a model of growth retardation in cystic fibrosis. Pediatr Res 59: 191–195
Weiner SA, Caputo C, Bruscia E, Ferreira EC, Price JE, Krause DS, Egan ME 2008 Rectal potential difference and the functional expression of CFTR in the gastrointestinal epithelia in cystic fibrosis mouse models. Pediatr Res 63: 73–78
Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME 2009 Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator−/− mice. Am J Respir Cell Mol Biol 40: 295–304
Barmeyer C, Ye JH, Sidani S, Geibel J, Binder HJ, Rajendran VM 2007 Characteristics of rat downregulated in adenoma (rDRA) expressed in HEK 293 cells. Pflugers Arch 454: 441–450
Verkman AS 1990 Development and biological applications of chloride-sensitive fluorescent indicators. Am J Physiol 259: C375–C388
Sidani SM, Kirchhoff P, Socrates T, Stelter L, Ferreira E, Caputo C, Roberts KE, Bell RL, Egan ME, Geibel JP 2007 DeltaF508 mutation results in impaired gastric acid secretion. J Biol Chem 282: 6068–6074
Egan ME, Glockner-Pagel J, Ambrose C, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S, Wagner CA, Geibel J, Caplan MJ 2002 Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 8: 485–492
Hoffman JF, Geibel JP 2005 Fluorescent imaging of Cl− in Amphiuma red blood cells: how the nuclear exclusion of Cl− affects the plasma membrane potential. Proc Natl Acad Sci USA 102: 921–926
Rasmussen H 1970 Cell communication, calcium ion, and cyclic adenosine monophosphate. Science 170: 404–412
Jin CH, Segawa A, Miyaura C, Tanaka H, Abe E, Suda T 1988 Calcium is essential in the fusion of mouse alveolar macrophages induced by 1α,12-dihydroxyvitaminD3. J Cell Physiol 137: 110–116
Holian A, Daniele RP 1982 The role of calcium in the initiation of superoxide release from alveolar macrophages. J Cell Physiol 113: 87–93
Hofer AM, Brown EM 2003 Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4: 530–538
Joris L, Dab I, Quinton PM 1993 Elemental composition of human airway surface fluid in healthy and diseased airways. Am Rev Respir Dis 148: 1633–1637
Gilljam H, Ellin A, Strandvik B 1989 Increased bronchial chloride concentration in cystic fibrosis. Scand J Clin Lab Invest 49: 121–124
Verkman AS, Galietta LJ 2009 Chloride channels as drug targets. Nat Rev Drug Discov 8: 153–171
Whittemore ER, Korotzer AR, Etebari A, Cotman CW 1993 Carbachol increases intracellular free calcium in cultured rat microglia. Brain Res 621: 59–64
Mathes C, Thompson SH 1994 Calcium current activated by muscarinic receptors and thapsigargin in neuronal cells. J Gen Physiol 104: 107–121
Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP 1990 Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA 87: 2466–2470
Davis PB 2006 Cystic fibrosis since 1938. Am J Respir Crit Care Med 173: 475–482
Brennan S, Sly PD, Gangell CL, Sturges N, Winfield K, Wikstrom M, Gard S, Upham JW 2009 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur Respir J 34: 655–661
Thomas GR, Costelloe EA, Lunn DP, Stacey KJ, Delaney SJ, Passey R, McGlinn EC, McMorran BJ, Ahadizadeh A, Geczy CL, Wainwright BJ, Hume DA 2000 G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages. J Immunol 164: 3870–3877
Gallin EK 1986 Ionic channels in leukocytes. J Leukoc Biol 39: 241–254
Eder C 1998 Ion channels in microglia (brain macrophages). Am J Physiol 275: C327–C342
Ikuma M, Welsh MJ 2000 Regulation of CFTR Cl− channel gating by ATP binding and hydrolysis. Proc Natl Acad Sci USA 97: 8675–8680
House MG, Kohlmeier L, Chattopadhyay N, Kifor O, Yamaguchi T, Leboff MS, Glowacki J, Brown EM 1997 Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 12: 1959–1970
Sellers ZM, De Arcangelis V, Xiang Y, Best PM 2010 Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(−) channel activity to maintain contraction rate. J Physiol 588: 2417–2429
Wei L, Vankeerberghen A, Cuppens H, Eggermont J, Cassiman JJ, Droogmans G, Nilius B 1999 Interaction between calcium-activated chloride channels and the cystic fibrosis transmembrane conductance regulator. Pflugers Arch 438: 635–641
Kunzelmann K, Mall M, Briel M, Hipper A, Nitschke R, Ricken S, Greger R 1997 The cystic fibrosis transmembrane conductance regulator attenuates the endogenous Ca2+ activated Cl− conductance of Xenopus oocytes. Pflugers Arch 435: 178–181
Ribeiro CM 2006 The role of intracellular calcium signals in inflammatory responses of polarised cystic fibrosis human airway epithelia. Drugs R D 7: 17–31
Antigny F, Norez C, Cantereau A, Becq F, Vandebrouck C 2008 Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells. Respir Res 9: 70
Antigny F, Norez C, Becq F, Vandebrouck C 2008 Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR. Cell Calcium 43: 175–183
Ribeiro CM, Paradiso AM, Schwab U, Perez-Vilar J, Jones L, O'Neal W, Boucher RC 2005 Chronic airway infection/inflammation induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem 280: 17798–17806
Mueller C, Braag SA, Keeler A, Hodges C, Drumm M, Flotte TR 2011 Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol 44: 922–929
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by NIH 5T32HL07272 [to A.S.], CFF (SHENOY10DO) and (EGANG08G, 10G), and NIH (NHLBI) HL093004 [to M.E.E.].
The authors report no conflicts of interest.
Rights and permissions
About this article
Cite this article
Shenoy, A., Kopic, S., Murek, M. et al. Calcium-Modulated Chloride Pathways Contribute to Chloride Flux in Murine Cystic Fibrosis-Affected Macrophages. Pediatr Res 70, 447–452 (2011). https://doi.org/10.1203/PDR.0b013e31822f2448
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/PDR.0b013e31822f2448
This article is cited by
-
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
Nature Communications (2015)
-
Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation
Nature Biotechnology (2015)